Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c7924902ba2038a72deb1fc3bd6145f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3474163988bef091f57392c448f942b9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16743 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate |
1991-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f3aa2c342e05f33f9976482c62bbaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae49e45c26bc922806917f6ac9816ef |
publicationDate |
1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9201057-A1 |
titleOfInvention |
Ehv-4 glycoprotein vaccine |
abstract |
The invention is concerned with the glycoproteins gH and gC of EHV-4 which can be used to vaccinate horses against EHV-4 infection. The invention also relates to nucleic acid sequences encoding the EHV-4 gH and gC polypeptides. Said sequences can be used for the preparation of a subunit or vector vaccine. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6156319-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0507179-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807557-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6193983-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6544526-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6225111-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5731188-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5855083-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6541459-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922327-A |
priorityDate |
1990-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |